Search results for " COVID-19" in Articles / App Notes
Article
Novavax Reports on Two Vaccine Efficacy Studies
Novavax announced on June 14, 2021, results from two studies of is recombinant nanoparticle protein-based COVID-19 vaccine; in a large study, the vaccine candidate demonstrated 90.4% efficacy overall …
Article
Enhancing Resins Addresses Purification Concerns
Resins have been seen as one tool that can address the purification needs of new COVID-19 vaccines as well as the existing challenges in the downstream processing of increasingly complex biologic moda…
Article
Single-Use Technologies Prove Effective for Viral Vector Process Development
“The simple reality is that the COVID-19 pandemic has shown the benefits of single-use systems in that it would not have been possible to deploy the viral vaccines in the time and the scale that has b…
Article
Top Process Development Trends for 2021 and a Look into 2022
And thanks to the spotlight COVID-19 vaccines put on mRNA therapies, they are being studied for use in cancers, including cancer vaccines, and other vaccinations such as the flu and bacterial infectio…
Article
Pandemic Alters Policies and Practices for Drug Development and Regulation
The desperate need for new vaccines and therapies to tame the deadly COVID-19 virus required new policies and procedures for how biopharma companies select, test, and manufacture medical products—and …
Article
Track-and-Trace Progress Benefits Supply-Chain Security Efforts
Since the COVID-19 pandemic struck, there has been little news of serialization breakthroughs, as manufacturers and their supply partners have focused on getting new therapeutics and vaccines to patie…
Article
Process Development: 2020 Reflections and 2021 Possibilities
Among the many vaccine challenges in relation to the urgency provoked by COVID-19 are safety and the ability to scale up the manufacturing process. Scaling up viral vector and virus manufacturing proc…
Article
Report from the 12th Plasma Product Biotechnology Forum
After a prolonged break due to the Covid-19 pandemic, there was a great appetite to meet again and discuss the latest developments of importance to the industry. The 12th PPB conference, held in Novem…
Article
See How Solis BioDyne Turned to Cytiva to Support Production Ramp-Up
Click here to read more>>
Solis BioDyne is one of the many life sciences companies that experienced a dramatic increase in demand for its solutions during the COVID-19 pandemic. In a collabora…
Article
Innovative Chromatography Resins Can Improve Purity and Quality
In February of 2021, Repligen launched a new resin (NGL COVID-19 Spike Protein Affinity Resin) for the purification of COVID-19 vaccines. This resin provides vaccine manufacturers the ability to quick…